Cancer Targeted Technology's Grant

Cancer Targeted Technology raised a round of funding on May 04, 2015. Investors include National Institutes of Health.

Cancer Targeted Technology (CTT) is a biotechnology company commercializing unique small molecule inhibitors to pivotal enzyme targets in cancer. Its first product, CTT-54, recognizes the molecular ta…

Articles about Cancer Targeted Technology's Grant: